Quick Answer
HNO International, Inc. reported Stockholders Equity of -$1.63 million for the year ending 2025.
- HNO International, Inc. showed a decrease of -16.6% in Stockholders Equity from 2024 to 2025.
- This data is from HNO International, Inc.'s annual report (Form 10-K), filed with the SEC on February 6, 2026.
- XBRL data for this metric is available from 2021 to 2025 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2022: -$461.5 thousand | Q3 2022: -$832.0 thousand | Q1 2023: -$928.3 thousand | Q2 2023: -$1.23 million | Q3 2023: $296.1 thousand | Q1 2024: -$574.7 thousand | Q2 2024: -$1.01 million | Q3 2024: -$1.07 million | Q4 2024: -$1.40 million | Q1 2025: -$1.75 million | Q2 2025: -$1.69 million | Q3 2025: -$1.56 million | Q4 2025: -$1.63 million | Q1 2026: -$1.70 million.
- Over the full 5 years of available data (2021 to 2025), HNO International, Inc.'s Stockholders Equity has declined by 4,067.1%.
- Historical annual values: Fiscal year 2025: -$1.63 million | Fiscal year 2024: -$1.40 million | Fiscal year 2023: -$193.1 thousand | Fiscal year 2022: -$1.11 million | Fiscal year 2021: -$39.1 thousand.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: